Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptoms of heartburn \>2 days per week off antireflux therapy, defined by a burning feeling rising from the stomach or lower chest up towards the neck~* Symptoms of gastroparesis \>1 month in duration, defined by nausea, vomiting, bloating, dyspepsia, early satiety, or effortless regurgitation.~* Prior abnormal 4-hour gastric emptying scan within the past 3 years~Exclusion Criteria:~* History of esophageal or gastric surgery~* Severe gastroparesis with any of the following: vomiting with dehydration requiring IV hydration, hospitalization, weight loss \>10 % pre-illness weight, requiring feeding jejunostomy tubes~* Presence of gastric electrical stimulator~* Symptoms of retching with vomiting more than 2 days per week~* Diagnosis of diabetes~* Disorders of small bowel motility (such as pseudo-obstruction or dumping syndrome)~* Disorders of small bowel absorption~* Diagnosis of gastric outlet, small bowel or colon mechanical obstruction~* Diagnosis of acid hypersecretory syndrome~* Disorders affecting proton pump inhibitor metabolism (such as liver failure)~* Known allergy or side effects to proton pump inhibitor~* Non-ambulatory patients: bed-ridden, nursing home resident, etc.~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Immediate-release omeprazole release first (Type: EXPERIMENTAL): subjects receive immediate release omeprazole for 7 days then delayed release for 7 days
- Delayed-release omeprazole first (Type: EXPERIMENTAL): subjects receive delayed release omeprazole for 7 days then immediate release for 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).